Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Bacoside A3 is a triterpenoid saponin first isolated from B. monniera.1 Bacoside A3 inhibits the ATP-binding cassette transporter P-glycoprotein (P-gp), decreasing efflux 4-fold compared with control in vitro.2 An extract containing bacoside A3 and bacopaside II (4 and 1.3 µg/mg extract, respectively) administered for eight days at a dose of 10-30 mg/kg reduces opioid withdrawal-induced depression in mice using the forced swim test.3 Bacoside A3 also has antioxidant properties following liver and kidney damage induced by street heroin in rats.4
WARNING This product is not for human or veterinary use.
1. Bacoside A3--
2. In vitro effects of standardized extract of Bacopa monniera and its five individual active constituents on human P-
3. Inhibitory effect of bacopasides on spontaneous morphine withdrawal induced depression in mice. Phytother. Res. 28(6), 937-939 (2014).
4. Beneficial effects of Bacopa monnieri extract on opioid induced toxicity. Heliyon 2(2), e00068 (2016).